pegylated interferons, plump thighs , copegasus, hepatitis c treatments, drugs, crystallography, reference, plump lip , tests, dosing, symptoms, plump mature , treatments for nonalcoholic fatty liver diseasee, fatty ass , fatty acid definition , hep c, n 3 polyunsaturated fatty acids , combo, maldi, encephalopathy, hepatitis a, copegus, hcv drug,
|
A biopsy specimen is also important for detecting histologically advanced disease, which may be clinically silent and undetected by aminotransferases or diagnostic imaging. Although there are no proven treatments, recommendations for patients with NAFLD include avoidance of clinical proteomics hepatotoxins and aggressive management of associated conditions, such as hypertriglyceridemia clinical proteomics and type 2 diabetes mellitus. The full text of this article is available online. Clark JM, Diehl AM. Nonalcoholic Fatty Liver Disease: An Underrecognized Cause of Cryptogenic Cirrhosis . JAMA. 2003;289:3000-3004. Home | CME On Demand | Live CME clinical proteomics Events | Case Studies | Slide Library | Literature Alert | Clinical Insights Calendar of Events | Multimedia Presentations | Treatment Guidelines | Pharmacist CE | Other Resources | Product Indications | Glossary Copyright © 2006 Thomson Professional Postgraduate Services®.
|